Found: 5
Select item for more details and to access through your institution.
Early consequences of the phospholamban mutation PLN‐R14del<sup>+/−</sup> in a transgenic mouse model.
- Published in:
- Acta Physiologica, 2024, v. 240, n. 3, p. 1, doi. 10.1111/apha.14082
- By:
- Publication type:
- Article
SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 4, p. 1020, doi. 10.1093/cvr/cvab123
- By:
- Publication type:
- Article
Selective SERCA2a activator as a candidate for chronic heart failure therapy.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-04874-9
- By:
- Publication type:
- Article
Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition.
- Published in:
- British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1849, doi. 10.1111/bph.12278
- By:
- Publication type:
- Article